Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Save on this medicine

Other brands with the same active ingredient

These brands contain the same active ingredient (Tiotropium). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.

Available as: 18 mcg

Indications & Uses

Tioriva Bexicap is indicated for:

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Adults over 18 years: The recommended dose of Tiotropium Dry Powder Inhaler capsule is 18 mcg (1 capsule) taken once daily using the device. The contents of the Tiotropium Dry Powder Inhaler capsules are meant for oral inhalation only and must be used only with the device. No dose adjustment is needed for elderly patients or those with liver or kidney impairment. However, patients with moderate to severe kidney impairment who are given Tiotropium capsule should be watched closely for anticholinergic effects.

Side Effects

Tiotropium's most common side effect is dry mouth. It's usually mild and often eases as treatment continues. Less commonly, individual patients have reported effects consistent with tiotropium's anticholinergic action, including constipation, a faster heartbeat, blurred vision, glaucoma, difficulty urinating, and urinary retention.

Cautions & Contraindications

Warnings & Precautions

Spirium, being an anticholinergic medicine, may aggravate conditions such as narrow-angle glaucoma, an enlarged prostate (prostatic hyperplasia), or bladder-neck obstruction. It should therefore be used cautiously in patients who have any of these conditions.

Contraindications

Tiotropium should not be used by patients who are known to be hypersensitive to atropine or atropine-like drugs, including ipratropium, or to any other ingredient in this product.

Drug Interactions

Open checker →
Moderate Cimetidine
Moderate Ranitidine
Last updated: 15 Aug 2026